Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)
- PMID: 38590945
- PMCID: PMC10999901
- DOI: 10.3892/br.2024.1768
Activity of isoflavone in managing polycystic ovary syndrome symptoms (Review)
Abstract
Polycystic ovary syndrome (PCOS), a hormonal and metabolic disorder manifested in women of reproductive age, is still being treated using drugs with side effects. As an alternative to these drugs, isoflavone, also identified as phytoestrogen, has anti-PCOS activity. Isoflavone can help relieve PCOS symptoms by lowering the level of testosterone, which causes hyperandrogenism, thereby normalizing the menstrual cycle and restoring normal ovarian morphology. Furthermore, isoflavone influences the improvement of the metabolic profile, which changes because of PCOS, as well as the reduction of inflammatory markers and oxidative stress. However, both significant and non-significant results have been generated on the activity of isoflavones in PCOS. The present review aims to discuss the existing literature on the effect of isoflavone on PCOS symptoms based on in vivo and clinical trial studies.
Keywords: hyperandrogenism; isoflavone; menstrual cycle; ovarian morphology; polycystic ovary syndrome.
Copyright: © 2024 Raihanah et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach.J Diabetes Metab Disord. 2018 Nov 13;17(2):277-285. doi: 10.1007/s40200-018-0371-5. eCollection 2018 Dec. J Diabetes Metab Disord. 2018. PMID: 30918863 Free PMC article.
-
Novel promising reproductive and metabolic effects of Cicer arietinum L. extract on letrozole induced polycystic ovary syndrome in rat model.J Ethnopharmacol. 2021 Oct 5;278:114318. doi: 10.1016/j.jep.2021.114318. Epub 2021 Jun 7. J Ethnopharmacol. 2021. PMID: 34111539
-
Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.BMC Complement Altern Med. 2014 Dec 18;14:511. doi: 10.1186/1472-6882-14-511. BMC Complement Altern Med. 2014. PMID: 25524718 Free PMC article. Review.
-
Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.Reprod Health. 2021 Jul 26;18(1):156. doi: 10.1186/s12978-021-01203-x. Reprod Health. 2021. PMID: 34311759 Free PMC article. Review.
Cited by
-
Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities.Redox Biol. 2025 Jul 17;85:103776. doi: 10.1016/j.redox.2025.103776. Online ahead of print. Redox Biol. 2025. PMID: 40694958 Free PMC article. Review.
References
-
- Barbosa G, de Sá L, Rocha D, Arbex A. Polycystic ovary syndrome (PCOS) and infertility. Open J Endocr Metab Dis. 2016;6:58–65.
-
- Ashraf S, Nabi M, Rasool SUA, Rashid F, Amin S. Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: A review. Egypt J Med Hum Genet. 2019;20(25)
Publication types
LinkOut - more resources
Full Text Sources
Research Materials